<DOC>
	<DOCNO>NCT02255890</DOCNO>
	<brief_summary>The aim registry ass recurrence prostate cancer 1 5 year , well change functional outcome ( e.g . incontinence erectile function ) baseline . Secondary objective establish indication lead treatment IRE Nanoknife® set safety assessment measure number complication adverse event .</brief_summary>
	<brief_title>Registry Irreversible Electroporation Ablation Prostate Cancer With Use Nanoknife Device</brief_title>
	<detailed_description>This international prospective observational multi-center study data consecutive patient 5 year prostate cancer undergo IRE collect . Data patient collect participate center 5-year period . Patients ' data baseline visit ( pre-IRE ) , peri-operative data follow 5 year record . Follow data collect accord follow schedule : 1 - 2 week surgery 1. st year : every 3 month 2. nd year : every three month 3. rd year : every 6 month 4. th 5th year : year . Data participating center collect electronic Case Report Forms ( eCRFs ) , use online Data Management System ( DMS ) , locate maintain CROES Office . The data collection patient participation study interfere choice treatment , sample collection , procedure treatment , entirely follow standard hospital practice , include follow .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Is diagnose histologically confirm prostate cancer Is schedule IRE Nanoknife® Has sign inform consent form No specific exclusion criterion define .</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>